ResMed (RMD +7%) trades up after beating FQ3 consensus estimates late yesterday. Net income...

|About: ResMed Inc. (RMD)|By:, SA News Editor

ResMed (RMD +7%) trades up after beating FQ3 consensus estimates late yesterday. Net income jumped 21% Y/Y, driven by higher-than-expected gross margins from strong growth in masks and a shift to higher-margin flow generators. Separately, Goldman ups the shares to Buy on the back of the blowout quarter.